ALK and non-small cell lung carcinoma: While Ota et al. found that ALK rearrangements can upregulate PD-L1 expression in NSCLC (Ota et al., 2015), Zeng et al. observed that PD-L1 was seldom expressed in ALK-positive tumor cells (Zeng et al., 2020).